SCHEMBL203283

SCHEMBL203283

NCc1ccc(C(=O)c2ccccc2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.61
SRD5A2 P31213 3/20 0.58
ATM Q13315 2/20 0.58
L3MBTL1 Q9Y468 2/20 0.58
TDP1 Q9NUW8 1/20 0.58
LOXL2 Q9Y4K0 2/20 0.54
PBRM1 Q86U86 1/20 0.53
HDAC3 O15379 1/20 0.53
HDAC6 Q9UBN7 1/20 0.53
NCOR2 Q9Y618 1/20 0.53
TAAR1 Q96RJ0 1/20 0.52
RAB9A P51151 2/20 0.50
MEN1 O00255 1/20 0.50
LMNA P02545 1/20 0.50
MAPT P10636 1/20 0.50
KMT2A Q03164 1/20 0.50
MAPK13 O15264 1/20 0.50
MAPK12 P53778 1/20 0.50
MAPK11 Q15759 1/20 0.50
MAPK14 Q16539 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2450035 0.98 ALDH1A1 (0.58) ALDH1A1SRD5A2ATML3MBTL1TDP1
SCHEMBL7150384 0.91 HDAC3 (0.61) ALDH1A1SRD5A2LOXL2HDAC3HDAC6
Trimethylammonium SCHEMBL27729915 0.91 HPGD (0.55) ALDH1A1SRD5A2ATML3MBTL1TDP1
Ethyl Chloride SCHEMBL29011196 0.91 ALDH1A1 (0.50) ALDH1A1SRD5A2ATML3MBTL1TDP1
SCHEMBL27536563 0.89 ALDH1A1 (0.49) ALDH1A1SRD5A2ATML3MBTL1TDP1
Hydrochloric Acid SCHEMBL8833446 0.89 HDAC3 (0.59) ALDH1A1SRD5A2LOXL2HDAC3HDAC6
Acrylic Acid SCHEMBL29144363 0.88 ALDH1A1 (0.47) ALDH1A1SRD5A2ATML3MBTL1TDP1
Acrylic Acid SCHEMBL29144364 0.88 ALDH1A1 (0.47) ALDH1A1SRD5A2ATML3MBTL1TDP1
SCHEMBL13885490 0.87 CES2 (0.65) ALDH1A1L3MBTL1LOXL2HDAC3HDAC6
SCHEMBL2900640 0.86 ATM (0.63) ALDH1A1SRD5A2ATML3MBTL1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10519339-B2 Method for applying a coating to a polymeric substrate SOPHION BIOSCIENCE A/S (DK) 2019-12-31 US claimed
CN-104769022-B A kind of method for being used to be applied to coating in polymeric substrates 索菲昂生物科学有限公司 2018-06-12 CN claimed
EP-2900740-B1 A METHOD FOR APPLYING A COATING TO A POLYMERIC SUBSTRATE SOPHION BIOSCIENCE AS (DK) 2017-08-23 EP claimed
US-20150240115-A1 METHOD FOR APPLYING A COATING TO A POLYMERIC SUBSTRATE THE TECHNICAL UNIVERSITY OF DENMARK (DK) 2015-08-27 US claimed
EP-2900740-A1 A METHOD FOR APPLYING A COATING TO A POLYMERIC SUBSTRATE Sophion Bioscience A/S (DK) 2015-08-05 EP claimed
CN-104769022-A A method for applying a coating to a polymeric substrate SOPHION BIOSCIENCE AS 2015-07-08 CN claimed
EP-0871607-A4 PHOTOSENSITIVE INTRAMOLECULAR ELECTRON TRANSFER COMPOUNDS SPECTRA GROUP LTD INC (US) 1999-09-29 EP claimed
US-5859084-A Radiation-curable compositions containing photoinitiators linked by a covalent bond BASF AKTIENGESELLSCHAFT (DE) 1999-01-12 US claimed
EP-0871607-A1 PHOTOSENSITIVE INTRAMOLECULAR ELECTRON TRANSFER COMPOUNDS SPECTRA GROUP LIMITED INC (US) 1998-10-21 EP claimed
WO-1997016406-A1 PHOTOSENSITIVE INTRAMOLECULAR ELECTRON TRANSFER COMPOUNDS SPECTRA GROUP LIMITED, INC. (US) 1997-05-09 WO claimed
CN-114080271-B Method of preparing a personal care composition comprising microcapsules 宝洁公司 2025-06-13 CN disclosed
CN-119591663-A Targeting cell surface glycoprotein interaction cross-linking agent and preparation method thereof 辽宁师范大学 2025-03-11 CN disclosed
CN-119499129-A Personal care composition preservative level optimization 宝洁公司 2025-02-25 CN disclosed
CN-115151310-B Sulfur-containing anti-dandruff compositions with enhanced efficacy and aesthetics 宝洁公司 2024-12-20 CN disclosed
CN-118541127-A Salt-containing soluble solid fibrous shampoo articles 宝洁公司 2024-08-23 CN disclosed
US-20040171034-A1 Compositions and methods for detection and isolation of phosphorylated molecules MOLECULAR PROBES, INC. 2004-09-02 US disclosed
US-20040147747-A1 Longer wavelength absorption than structurally similar dyes; staining; ligand and analyte detection; aromatic or heteroaromatic ring fused at 3,4-double bond MOLECULAR PROBES, INC. 2004-07-29 US disclosed
EP-0755949-B1 Radiation curable masses containing covalently bonded photoinitiators BASF AG (DE) 2000-04-12 EP disclosed
US-5859084-A Radiation-curable compositions containing photoinitiators linked by a covalent bond BASF AKTIENGESELLSCHAFT (DE) 1999-01-12 US disclosed
EP-0755949-A1 Radiation curable masses containing covalently bonded photoinitiators BASF AKTIENGESELLSCHAFT (DE) 1997-01-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040147747-A1 Longer wavelength absorption than structurally similar dyes; staining; ligand and analyte detection; aromatic or heteroaromatic ring fused at 3,4-double bond CYP3A4, CYP3A5, UGT1A4 ALDH1A1 148/4885SRD5A2 458/4885ATM 4765/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.